These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17609423)

  • 1. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.
    Mingozzi F; Hasbrouck NC; Basner-Tschakarjan E; Edmonson SA; Hui DJ; Sabatino DE; Zhou S; Wright JF; Jiang H; Pierce GF; Arruda VR; High KA
    Blood; 2007 Oct; 110(7):2334-41. PubMed ID: 17609423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B.
    Mingozzi F; Chen Y; Murphy SL; Edmonson SC; Tai A; Price SD; Metzger ME; Zhou S; Wright JF; Donahue RE; Dunbar CE; High KA
    Mol Ther; 2012 Jul; 20(7):1410-6. PubMed ID: 22565846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer.
    Cooper M; Nayak S; Hoffman BE; Terhorst C; Cao O; Herzog RW
    Hum Gene Ther; 2009 Jul; 20(7):767-76. PubMed ID: 19309290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.
    Unzu C; Hervás-Stubbs S; Sampedro A; Mauleón I; Mancheño U; Alfaro C; de Salamanca RE; Benito A; Beattie SG; Petry H; Prieto J; Melero I; Fontanellas A
    J Transl Med; 2012 Jun; 10():122. PubMed ID: 22704060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer.
    Hoffman BE; Martino AT; Sack BK; Cao O; Liao G; Terhorst C; Herzog RW
    Mol Ther; 2011 Jul; 19(7):1263-72. PubMed ID: 21386826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer.
    Cao O; Dobrzynski E; Wang L; Nayak S; Mingle B; Terhorst C; Herzog RW
    Blood; 2007 Aug; 110(4):1132-40. PubMed ID: 17438084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to AAV in clinical trials.
    Mingozzi F; High KA
    Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice.
    Sabatino DE; Mackenzie TC; Peranteau W; Edmonson S; Campagnoli C; Liu YL; Flake AW; High KA
    Mol Ther; 2007 Sep; 15(9):1677-85. PubMed ID: 17565352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy.
    Herzog RW; Fields PA; Arruda VR; Brubaker JO; Armstrong E; McClintock D; Bellinger DA; Couto LB; Nichols TC; High KA
    Hum Gene Ther; 2002 Jul; 13(11):1281-91. PubMed ID: 12162811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antigen-specific regulatory CD4+CD25+ T cells in tolerance induction after neonatal IP administration of AAV-hF.IX.
    Shi Y; Falahati R; Zhang J; Flebbe-Rehwaldt L; Gaensler KM
    Gene Ther; 2013 Oct; 20(10):987-96. PubMed ID: 23759700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.
    Jiang H; Couto LB; Patarroyo-White S; Liu T; Nagy D; Vargas JA; Zhou S; Scallan CD; Sommer J; Vijay S; Mingozzi F; High KA; Pierce GF
    Blood; 2006 Nov; 108(10):3321-8. PubMed ID: 16868252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle as a target for supplementary factor IX gene transfer.
    Hoffman BE; Dobrzynski E; Wang L; Hirao L; Mingozzi F; Cao O; Herzog RW
    Hum Gene Ther; 2007 Jul; 18(7):603-13. PubMed ID: 17594244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells.
    Dobrzynski E; Fitzgerald JC; Cao O; Mingozzi F; Wang L; Herzog RW
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4592-7. PubMed ID: 16537361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model.
    Mattar CNZ; Gil-Farina I; Rosales C; Johana N; Tan YYW; McIntosh J; Kaeppel C; Waddington SN; Biswas A; Choolani M; Schmidt M; Nathwani AC; Chan JKY
    Mol Ther; 2017 Aug; 25(8):1843-1853. PubMed ID: 28462816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.
    McIntosh JH; Cochrane M; Cobbold S; Waldmann H; Nathwani SA; Davidoff AM; Nathwani AC
    Gene Ther; 2012 Jan; 19(1):78-85. PubMed ID: 21716299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction.
    Shao W; Earley LF; Chai Z; Chen X; Sun J; He T; Deng M; Hirsch ML; Ting J; Samulski RJ; Li C
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to AAV in clinical trials.
    Mingozzi F; High KA
    Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer.
    Li H; Lin SW; Giles-Davis W; Li Y; Zhou D; Xiang ZQ; High KA; Ertl HC
    Mol Ther; 2009 Jul; 17(7):1215-24. PubMed ID: 19367258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.